The Business Development and Advisory team at Biosceptre is dedicated to advancing the company's strategic partnerships and funding opportunities to support the development of its groundbreaking cancer therapies targeting nf-P2X7. This team leverages industry expertise to identify new market potentials, build relationships with key stakeholders, and provide strategic guidance to ensure the successful commercialization of innovative treatments that differentiate between cancerous and healthy tissues.
View all